Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: A qualitative study

被引:29
|
作者
Shea, Christopher M. [1 ]
Gertner, Alex K. [1 ]
Green, Sherri L. [1 ]
机构
[1] Univ N Carolina, Chapel Hill, NC 27599 USA
关键词
Primary health care; medication assisted treatment; opioid use disorder; ECHO; implementation barriers; PROJECT ECHO; SPECIALISTS; ADDICTION; CAPACITY; CARE;
D O I
10.1080/08897077.2019.1694617
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Medication treatment for opioid use disorder (M-OUD) is underutilized, despite research demonstrating its effectiveness in treating opioid use disorder (OUD). The UNC Extension for Community Healthcare Outcomes for Rural Primary Care Medication Assisted Treatment (UNC ECHO for MAT) project was designed to evaluate interventions for reducing barriers to delivery of M-OUD by rural primary care providers in North Carolina. A key element was tele-conferenced sessions based on the University of New Mexico Project ECHO model, comprised of case discussions and didactic presentations using a "hub and spoke" model, with expert team members at the hub site and community-based providers participating from their offices (i.e., spoke sites). Although federal funders have promoted use of the model, barriers for providers to participate in ECHO sessions are not well documented. Methods: UNC ECHO for MAT included ECHO sessions, provider-to-provider consultations, and practice coaching. We conducted 20 semi-structured interviews to assess perceived usefulness of the UNC ECHO for MAT intervention, barriers to participation in the intervention, and persistent barriers to prescribing M-OUD. Results: Participants were generally satisfied with ECHO sessions and provider-to-provider consultations; however, perceived value of practice support was less clear. Primary barriers to participating in ECHO sessions were timing and length of sessions. Participants recommended recording ECHO sessions for viewing later, and some thought incentives for either the practice or provider could facilitate participation. Providers who had participated in ECHO sessions valued the expertise on the expert team; the team's ability to develop a supportive, collegial environment; and the value of a community of providers interested in learning from each other, particularly through case discussions. Conclusions: Despite the perceived value of ECHO, barriers may prevent consistent participation. Also, barriers to M-OUD delivery remain, including some that ECHO alone cannot address, such as Medicaid and private-insurer policies and availability of psychosocial resources.
引用
收藏
页码:54 / 64
页数:11
相关论文
共 50 条
  • [21] Impact of Office-based Opioid Treatment on Emergency Visits and Hospitalization in Adolescents with Opioid Use Disorder
    Walker, Kim S.
    Bonny, Andrea E.
    McKnight, Erin R.
    Nahata, Milap C.
    JOURNAL OF PEDIATRICS, 2020, 219 : 236 - 242
  • [22] Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice
    Cope, Kevin
    DeMicco, James
    Salib, Justina
    Michael, Mina
    Yakoub, Peter
    Daoud, Kirollos
    Cope, Rebecca
    JOURNAL OF ADDICTION MEDICINE, 2022, 16 (06) : 716 - 721
  • [23] Office-Based Methadone Treatment for Opioid Use Disorder and Pharmacy Dispensing: A Scoping Review
    McCarty, Dennis
    Bougatsos, Christina
    Chan, Brian
    Hoffman, Kim A.
    Priest, Kelsey C.
    Grusing, Sara
    Chou, Roger
    AMERICAN JOURNAL OF PSYCHIATRY, 2021, 178 (09): : 804 - 817
  • [24] Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program
    Furo, Hiroko
    Schwartz, Diane G.
    Sullivan, Ross W.
    Elkin, Peter L.
    SUBSTANCE ABUSE-RESEARCH AND TREATMENT, 2021, 15
  • [25] UNDERSTANDING AND OVERCOMING BARRIERS TO OFFICE-BASED PHYSICIANS' TREATMENT OF OPIOID ADDICTION
    Hutchinson, E.
    Rosenblatt, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (01) : 115 - 115
  • [26] Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study
    Mary L. Geist
    Andrea C. Radick
    Judith I. Tsui
    Kendra L. Blalock
    Addy Adwell
    Elsabeth Tamru
    Nancy C. Connolly
    Jocelyn R. James
    Addiction Science & Clinical Practice, 18
  • [27] Barriers to Engagement in Opioid Use Disorder Treatment After Buprenorphine Induction
    Simpson, Scott A.
    Hordes, Melissa
    Blum, Joshua
    Rinehart, Deborah
    Al-Tayyib, Alia
    JOURNAL OF ADDICTION MEDICINE, 2022, 16 (04) : 479 - 482
  • [28] Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study
    Geist, Mary L.
    Radick, Andrea C.
    Tsui, Judith I.
    Blalock, Kendra L.
    Adwell, Addy
    Tamru, Elsabeth
    Connolly, Nancy C.
    James, Jocelyn R.
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2023, 18 (01)
  • [29] The Association between Cocaine Use and Treatment Outcomes in Patients Receiving Office-Based Buprenorphine/Naloxone for the Treatment of Opioid Dependence
    Sullivan, Lynn E.
    Moore, Brent A.
    O'Connor, Patrick G.
    Barry, Declan T.
    Chawarski, Marek C.
    Schottenfeld, Richard S.
    Fiellin, David A.
    AMERICAN JOURNAL ON ADDICTIONS, 2010, 19 (01): : 53 - 58
  • [30] Retention in Office-Based Opioid Treatment and Impact on Emergency Department Use in Adolescents and Young Adults With Opioid Use Disorder
    Ramey, Olivia L.
    Bonny, Andrea E.
    Almodovar, Armando Silva
    Nahata, Milap C.
    JOURNAL OF ADOLESCENT HEALTH, 2023, 73 (01) : 148 - 154